Berlin, Germany

Klemens Angstwurm

This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klemens Angstwurm. Retrieved from https://idiyas.com/inventor/klemens-angstwurm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Klemens Angstwurm: Innovator in Pharmaceutical Chemistry

Introduction

Klemens Angstwurm is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. His work has led to advancements in the treatment of various medical conditions.

Latest Patents

Klemens holds a patent for "Prostane derivatives and the combination thereof with antibiotics." This invention showcases his expertise in creating effective pharmaceutical solutions that can enhance the efficacy of existing treatments.

Career Highlights

Klemens Angstwurm is currently employed at Schering Aktiengesellschaft, a prominent pharmaceutical company known for its research and development in healthcare. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, Klemens has worked alongside talented colleagues, including Jorg Weber and Peter Scholz. These collaborations have fostered an environment of innovation and creativity, leading to the development of new and effective pharmaceutical products.

Conclusion

Klemens Angstwurm's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to impact the industry positively, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…